fda warning letters glp-1 compounders september 2025 news 8, 2025: launches an import alert listing safe manufacturers – Partnership for Safe Medicines FDA issued 25 warning letters

Its staying whole while your body changes

Yes, for injectable GLP-1 medications like semaglutide and tirzepatide , there is no absorption interaction between fiber supplements and the injection itself

Improved metabolic flexibility research models report rapid shifts in body composition, including reductions in fat mass, without altering caloric intake

Lancet Glob Health 7, e1332e1345

In practical terms, products sold under the name DSIP are typically marketed as research chemicals , not as approved or compounded medications which means there is no approval-backed assurance of identity, purity, dosing, or clinical appropriateness, and significant sourcing risk

Obesity (Silver Spring) 31 , 350362 (2023)